echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Thyroid: Metabolic Syndrome and Risk of Thyroid Cancer

    Thyroid: Metabolic Syndrome and Risk of Thyroid Cancer

    • Last Update: 2020-06-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    The relationship between metabolic syndrome and its components and the risk of thyroid cancer is not clearIn a recent study published in the authoritative journal Thyroid, researchers conducted a large-scale, nationwide, population-based cohort study to explore the associationThe researchers analyzed 9890917 adults without thyroid cancer in the National Health Insurance Health Check database between January 1 and December 31, 2009The subjects had at least three of the five components of metabolic syndrome: abdominal obesity, hypertriglyceride, low HDL cholesterol, high blood pressure, and high blood sugarThe multivariate Cox proportional risk model is used to assess the risk of thyroid cancerDuring an average of 7.2 years of follow-up, researchers found 77,133 new cases of thyroid cancerThe risk of thyroid cancer in patients with metabolic syndrome was higher than in patients with non-metabolic syndrome (1.15 HR; 95% CI was 1.13-1.17)In the obesity group (HR 1.10, 95% CI was 1.07-1.13), there was a significant correlation between metabolic syndrome and thyroid cancer risk, while the non-obesity group (HR 1.002, 95% CI was 0.98-1.03) was not statistically significantThe effect of metabolic syndrome on thyroid cancer risk varies from obesity to obesity (interaction P-0.017)Subjects with all five components of metabolic syndrome had a 39 percent higher risk of thyroid cancer than those without any component (HR was 1.39; 95% CI was 1.33-1.44)Subjects in the obesity group (HR 1.29; 95% CI 1.21-1.38) had a higher risk of thyroid cancer in all five groups, while the non-obese group had a higher risk of thyroid cancer (HR was 1.06; 95% CI was 0.98-1.14)There was a significant interaction between the number of metabolic syndrome components and obesity (interaction P 0.001)Because of the combined effect of obesity and metabolic syndrome on thyroid cancer risk, obese men with metabolic syndrome had the highest risk of thyroid cancer (HR 1.58, 95% CI 1.52-1.64) compared to men without metabolic syndrome, but not in obese women with metabolic syndromeIt can be seen that metabolic syndrome is associated with an increased risk of thyroid cancer in the general populationIn obese people, the risk of metabolic syndrome and thyroid cancer is more pronouncedIn men, metabolic syndrome and obesity are associated with a higher risk of thyroid cancer, but not in women
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.